Barclays Positive on BridgeBio Pharma (BBIO): 'We expect continued strength from Attruby launch'
Go back to Barclays Positive on BridgeBio Pharma (BBIO): 'We expect continued strength from Attruby launch'| (NASDAQ: BBIO) | Delayed: 79.86 -1.35 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.21 | 52 Week High | $ | |||
| Open | $80.14 | 52 Week Low | $ | |||
| Day High | $80.56 | P/E | N/A | |||
| Day Low | $78.60 | EPS | $ | |||
| Volume | 3,094,032 | |||||
